At the end 2011, the Dutch rating agency Sustainalytics, which specializes in sustainability issues, conducted a comparative analysis of the sustainability performance of companies in the sector Pharma, Biotechnology and Lifescience. The analysis follows the ESG (environment, social, governance) approach. The companies are assessed in terms of how well they meet requirements in the areas of environmental management and climate protection, products and services, employees, suppliers, corporate citizenship and corporate ethics.
On a scale of 1 to 100, Bayer was awarded 70 points, thus reaching 10th place out of 101 companies.
In February 2012 Sustainalytics closely examined the sustainability performance of the German DAX 30 companies for the fifth time. With an overall result of 70.5 points, Bayer occupies 16th place in this cross-sector ranking.